NewcelX Company
NewcelX (formerly NLS Pharma) is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.
Employee Number:
11-50
Headquarters:
Stans, Nidwalden, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 41 618 80 00
Investors:
Biotechnology Value Fund, Yorkville Advisors
Ipo Status:
public
Stock Symbol:
NCEL
City:
Stans
Region:
Nidwalden
Country:
Switzerland
Founders:
Alex Zwyer, Bruno Figadère, Eric Konofal